HAYA Therapeutics SA Revenue and Competitors

Lausanne/Epalinges,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • HAYA Therapeutics SA's estimated annual revenue is currently $8.1M per year.(i)
  • HAYA Therapeutics SA's estimated revenue per employee is $149,259

Employee Data

  • HAYA Therapeutics SA has 54 Employees.(i)
  • HAYA Therapeutics SA grew their employee count by 20% last year.

HAYA Therapeutics SA's People

NameTitleEmail/Phone
1
Chief Business OfficerReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Senior Director, BiomarkersReveal Email/Phone
4
Director Biology and Functional GenomicsReveal Email/Phone
5
Senior Director, BiomarkersReveal Email/Phone
6
Director, Computational BiologyReveal Email/Phone
7
Preclinical / Regulatory Project ManagerReveal Email/Phone
8
Preclinical Project ManagerReveal Email/Phone
9
Project Lead - OncologyReveal Email/Phone
10
Bioinformatics ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is HAYA Therapeutics SA?

HAYA Therapeutics is a Swiss-based pre-clinical early stage biopharmaceutical company dedicated to treating fibrotic diseases through the discovery and development of innovative targeted first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNAs. Our vision is to be the first company and a world leader in translating long noncoding RNA discoveries into breakthrough therapies to monitor and treat patients with debilitating diseases caused by fibrosis.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$8.1M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator